Evidence map›Paper›PMID 38474036›Full record

ReviewInternational journal of molecular sciences2024

Transforming Growth Factor Beta and Alveolar Rhabdomyosarcoma: A Challenge of Tumor Differentiation and Chemotherapy Response.

Bhavya Bhushan, Rosa Iranpour, Amirmohammad Eshtiaghi, Simone C da Silva Rosa, Benjamin W Lindsey, Joseph W Gordon, Saeid Ghavami

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Pathology, Diagnosis, and Management of Sarcoma.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bhavya BhushanDepartment of Human Anatomy and Cell Science, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.
Rosa IranpourDepartment of Human Anatomy and Cell Science, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.
Amirmohammad EshtiaghiDepartment of Human Anatomy and Cell Science, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.
Simone C da Silva RosaDepartment of Human Anatomy and Cell Science, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.ORCID 0000-0002-3732-3781
Benjamin W LindseyDepartment of Human Anatomy and Cell Science, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.
Joseph W GordonDepartment of Human Anatomy and Cell Science, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.ORCID 0000-0002-0061-2168
Saeid GhavamiDepartment of Human Anatomy and Cell Science, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.ORCID 0000-0001-5948-508X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alveolar rhabdomyosarcoma (ARMS), an invasive subtype of rhabdomyosarcoma (RMS), is associated with chromosomal translocation events resulting in one of two oncogenic fusion genes,

Indexed as

RhabdomyosarcomaRhabdomyosarcoma, AlveolarEpithelial-Mesenchymal TransitionHumansOncogene Proteins, FusionPaired Box Transcription FactorsTransforming Growth Factor betaTransforming Growth Factor beta1Oncogene Proteins, FusionPaired Box Transcription FactorsTransforming Growth Factor betaTransforming Growth Factor beta1all-trans retinoic acidcombination therapyrhabdomyosarcomaTGF-beta1

Identifiers

PMID38474036
PMCPMC10932473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.